Wide-awake local anaesthesia no tourniquet-assisted subcutaneous anterior ulnar nerve transposition in cubital tunnel syndrome: A retrospective evaluation

清醒状态下局部麻醉、无止血带辅助皮下尺神经前移位术治疗肘管综合征:一项回顾性评估

阅读:1

Abstract

Although several studies have demonstrated the successful use of wide-awake local anesthesia no tourniquet (WALANT) technique in cubital tunnel decompression, no prior study has investigated its use in anterior ulnar nerve transposition. This study aimed to retrospectively evaluate the outcomes of patients who underwent ulnar nerve decompression and subcutaneous anterior transposition using WALANT. A total of 41 surgeries were performed on 40 patients between August 2012 and March 2024 by a single surgeon. Patient data including age, sex, surgical side, Dellon satisfaction scale scores, postoperative complications, and satisfaction with anesthesia were collected. All procedures were performed using WALANT. Twelve (30%) patients were female and 28 (70%) were male and the mean postoperative follow-up period was 5.8 weeks (range 4-9 weeks). In the preoperative evaluation according to the Dellon scale, 12 (30%) patients had mild disease, 23 (57.5%) had moderate moderate, 5 (12.5%) had severe disease. Patient satisfaction was evaluated as bad in 3 patients (7.5%), moderate in 11 patients (27.5%) and good in 26 patients (65%). A significant negative correlation was observed between age and satisfaction questionnaire scores (r = -0.27, P = .023). Age also had a significant effect on the likelihood of conversion to general anesthesia (P = .0018). The WALANT anesthesia technique for anterior subcutaneous transposition of the ulnar nerve in cubital tunnel syndrome is safe and effective. The most important point in this regard is patient selection. A prospective cohort study with a larger cohort and longer follow-up time is required to monitor the long-term clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。